At Celltrion USA, partnerships are about shared purpose.

We work side by side with healthcare providers, patient organizations, and industry partners who believe, as we do, that everyone should have access to high-quality biologic care. By combining our capabilities with our partners’ expertise, we open new possibilities for patients and strengthen the systems that serve them.

Want to advance the science?

Learn more about investigator‑initiated trials

Care that goes beyond the clinic.

We believe our responsibility extends far beyond the treatments we deliver.

Our world

Committed to reducing our environmental footprint, setting safety standards beyond regulatory requirements, and working toward zero environmental incidents.

Our partners

Collaborations designed to deliver real benefits: expanding access, supporting community programs, and investing in education for patients and providers.

Our standards

Guided by transparency, accountability, and uncompromising ethics.

Why collaborate with Celltrion USA

Choosing Celltrion USA means working with a partner who pairs proven results with forward-looking ambition:

Biosimilar leadership with lasting impact: First in the world to launch a monoclonal antibody biosimilar, substantially reducing annual treatment costs and enabling more patients to receive care. Pipeline targeting 20+ launches by 2030 across immunology, ophthalmology, allergy, endocrinology, and oncology.

Integrated capabilities from lab to launch: 32% of our workforce in R&D, $300M+ invested to date, and 20% of annual revenue reinvested into innovation.

Global scale with local strength: Products approved in 110+ countries, 12 manufacturing sites , 46+ subsidiaries worldwide, and a direct sales network in 90 markets.

Operational excellence: 316,000L FDA/EMA cGMP-certified capacity, expanding to 571,000L by 2030 (+80%), with a >99% production success rate.

Proven portfolio growth: Currently 12 approved biopharmaceuticals, with more in the pipeline.

Partnerships with purpose

Every collaboration is an opportunity to create meaningful change:

Reliable supply and manufacturing: Control from R&D through delivery, with US manufacturing expansion underway for greater supply resilience.

Expanding access: Launches like STOBOCLO® and OSENVELT® and programs such as the Costco Member Prescription Program make treatments more affordable and accessible.

Patient support that lasts: Through Celltrion CONNECT® and CARES® Co-pay Assistance, patients receive guidance, education, and financial help—strengthened through advocacy and care network collaborations.

Opportunities to collaborate

We welcome partnerships that:

  • Advance commercial reach and therapeutic access
  • Leverage our scale for manufacturing and distribution
  • Build community programs that improve education and equity
Connect with us

Celltrion sustainability report

Sustainability is built into everything we do—from lowering emissions and sourcing responsibly to advancing renewable energy. At Celltrion, protecting the planet goes hand in hand with delivering better care for patients and communities.

Read the report